Filter
1137
Filtered Results: 1137
Text search:
antibodies
Featured
Recommendations
149
New Publications
286
Language
Document type
No document type
565
Guidelines
239
Studies & Reports
140
Manuals
60
Fact sheets
56
Strategic & Response Plan
27
Training Material
20
Situation Updates
10
Brochures
6
Resource Platforms
5
Infographics
4
Videos
4
App
1
Countries / Regions
India
93
Global
53
Nigeria
23
Nepal
22
Latin America and the Carribbean
21
South Africa
20
Tanzania
18
Philippines
16
Africa
15
Indonesia
14
Kenya
13
Middle East and North Africa
13
Western and Central Europe
13
Germany
12
Russia
12
Ethiopia
12
Liberia
12
Syria
11
Brazil
11
Sierra Leone
10
Malawi
10
West and Central Africa
10
East and Southern Africa
10
Uganda
10
Rwanda
9
Zambia
9
Congo, Democratic Republic of
7
Eastern Europe
7
Myanmar / Burma
7
Venezuela
6
Bangladesh
6
Namibia
6
Colombia
5
Ukraine
5
Yemen
5
Burkina Faso
4
Afghanistan
4
Peru
4
Guinea
4
South–East Asia Region
4
Pakistan
4
Lesotho
3
Turkey
3
Cameroon
3
Zimbabwe
3
Mozambique
3
USA
3
Cambodia
3
Asia
3
Saudi Arabia
3
Spain
3
Lebanon
3
Mali
3
South Sudan
3
Ecuador
3
Mexico
2
Ghana
2
Senegal
2
Niger
2
Qatar
2
Haiti
2
Jordan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
France
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Vietnam
2
Egypt
2
Sudan
2
Georgia
2
Chad
2
Libya
2
Botswana
2
Iraq
2
Somalia
2
Madagascar
2
Eswatini/ Swaziland
2
North Macedonia
1
Tajikistan
1
El Salvador
1
Serbia
1
Benin
1
Togo
1
China
1
Kazakhstan
1
Chile
1
Iran
1
Congo-Brazzaville
1
Uzbekistan
1
Morocco
1
Mauritania
1
Armenia
1
Dominican Republic
1
Western Pacific Region
1
Jamaica
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Djibouti
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
369
Clinical Guidelines
176
Public Health
48
Women & Child Health
44
Pharmacy & Technologies
41
Capacity Building
26
Key Resources
16
Toolboxes
COVID-19
215
HIV
119
NTDs
88
Rapid Response
70
Ebola
47
TB
35
Zika
35
Refugee
23
Mental Health
21
Pharmacy
20
NCDs
20
Caregiver
16
Planetary Health
13
Polio
13
AMR
12
Cholera
6
Natural Hazards
4
Conflict
4
Health Financing Toolbox
3
Specific Hazards
2
Disability
2
Global Health Education
2
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for ...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Revised and expanded version of the Guidelines
